Simpple vs SuperX AI Technology
SPPL and SUPX side by side, both in management and public relations services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How SPPL and SUPX compare
SuperX AI Technology grew revenue faster over the last twelve months (1879% versus 56.6% for Simpple).
Simpple keeps more of each dollar of sales as profit, with a net margin of −70.8% compared with −528% at SuperX AI Technology.
SuperX AI Technology scores higher on the StockData Score (7 against 3 for Simpple), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | SPPL | SUPX |
|---|---|---|
| Size and price | ||
| Share price | $2.81 | $5.05 |
| Change, 1 year | −43.9% | −89.7% |
| Change, 5 years | – | −73.9% |
| Beta (5Y) | 2.70 | 0.19 |
| Employees | 39 | 40 |
| StockData Score | ||
| Total score | 3 | 7 (better) |
| Valuation score | 0 | 0 |
| Growth score | 1 | 2 (better) |
| Performance score | 0 | 0 |
| Health score | 2 | 5 (better) |
| Dividend score | 0 | 0 |
| Growth | ||
| Revenue growth (TTM) | 56.6% | 1879% (better) |
| Profitability | ||
| Gross margin | 49.6% (better) | −5.4% |
| Operating margin | −62.8% (better) | −500% |
| Net margin | −70.8% (better) | −528% |
| FCF margin | −40.1% (better) | −390% |
| Return on equity | −90.8% (better) | −102% |
| Return on invested capital | −66.8% (better) | −185% |
| Financial health | ||
| Debt / equity | 0.22 (better) | 0.00 |
| Interest coverage | −7.4× | – |
| Current ratio | 1.46 | 19.73 (better) |
| Piotroski F-score | 5 (better) | 4 |
| Ownership | ||
| Held by institutions | – | 4.3% |
| Held by insiders | 0.00% | 0.51% |
| Insider net buying, 12 months | −$1 | – |
| Short interest, % of float | – | 2.2% |
Go deeper
- SPPL stock overview
- SPPL income statement
- SPPL valuation and score
- SUPX stock overview
- SUPX income statement
- SUPX valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.